Alexander Dewerth

617 total citations
14 papers, 401 citations indexed

About

Alexander Dewerth is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Alexander Dewerth has authored 14 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hepatology. Recurrent topics in Alexander Dewerth's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Mechanisms and Therapy (3 papers) and Liver physiology and pathology (3 papers). Alexander Dewerth is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Mechanisms and Therapy (3 papers) and Liver physiology and pathology (3 papers). Alexander Dewerth collaborates with scholars based in Germany, United States and Switzerland. Alexander Dewerth's co-authors include Michael Kormann, Satheesh Elangovan, Behnoush Khorsand, Aliasger K. Salem, Liu Hong, Sorin Armeanu–Ebinger, Steven W. Warmann, Jörg Fuchs, Dale R. Sumner and Anh‐Vu Do and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Alexander Dewerth

14 papers receiving 397 citations

Peers

Alexander Dewerth

GENET

PRM

ONCOL

Pingguo Liu China

Laura A. Varas Cuba

Dai Ming Fan China

Kiyoto Takehara Japan

Kathrin Klutz Germany

Betty Reinboth Australia

Benjamin Jones United States

Jens Endruschat United Kingdom

Reinhold Pollner Germany

E Satoh Japan

Pingguo Liu China

Alexander Dewerth

194 ×0.8

31 ×0.4

GENET

35 ×0.5

34 ×0.6

PRM

98 ×1.8

ONCOL

Citations per year, relative to Alexander Dewerth Alexander Dewerth (= 1×) peers Pingguo Liu

Countries citing papers authored by Alexander Dewerth

Since Specialization

Citations

This map shows the geographic impact of Alexander Dewerth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Dewerth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Dewerth more than expected).

Fields of papers citing papers by Alexander Dewerth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Dewerth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Dewerth. The network helps show where Alexander Dewerth may publish in the future.

Co-authorship network of co-authors of Alexander Dewerth

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Dewerth. A scholar is included among the top collaborators of Alexander Dewerth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Dewerth. Alexander Dewerth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Haque, A.K.M. Ashiqul, Alexander Dewerth, Justin S. Antony, et al.. (2018). Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis. Scientific Reports. 8(1). 16776–16776. 64 indexed citations

Khorsand, Behnoush, Satheesh Elangovan, Liu Hong, et al.. (2017). A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9. The AAPS Journal. 19(2). 438–446. 66 indexed citations

Kormann, Michael, Alexander Dewerth, Praveen Baskaran, et al.. (2017). Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity. PLoS ONE. 12(8). e0183526–e0183526. 22 indexed citations

Dewerth, Alexander, et al.. (2015). Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies. PubMed. 2(1). 11–11. 16 indexed citations

Elangovan, Satheesh, Behnoush Khorsand, Anh‐Vu Do, et al.. (2015). Chemically modified RNA activated matrices enhance bone regeneration. Journal of Controlled Release. 218. 22–28. 95 indexed citations

Armeanu–Ebinger, Sorin, et al.. (2014). Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma. Experimental Cell Research. 331(1). 97–104. 17 indexed citations

Lieber, Justus, et al.. (2013). BH3 mimetics reduce adhesion and migration of hepatoblastoma and hepatocellular carcinoma cells. Experimental Cell Research. 319(10). 1443–1450. 8 indexed citations

Lieber, Justus, et al.. (2012). Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737. Oncology Reports. 29(2). 646–652. 8 indexed citations

Dewerth, Alexander, Jüergen Thomale, Verena Ellerkamp, et al.. (2012). Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts. British Journal of Cancer. 108(2). 334–341. 26 indexed citations

10.

Dewerth, Alexander, Justus Lieber, Verena Ellerkamp, et al.. (2012). In vitro evaluation of the Aurora kinase inhibitor VX-680 for Hepatoblastoma. Pediatric Surgery International. 28(6). 579–589. 6 indexed citations

11.

Dewerth, Alexander, et al.. (2012). Effect of duplex drugs linking 2′-deoxy-5-fluorouridine (5-FdU) with 3′-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines. Pediatric Surgery International. 29(2). 121–127. 8 indexed citations

12.

Dewerth, Alexander, et al.. (2012). The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture. Liver International. 33(1). 127–136. 42 indexed citations

13.

Dewerth, Alexander, et al.. (2011). Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI‐Foxn1^nu mice. Liver International. 32(4). 574–581. 12 indexed citations

14.

Dewerth, Alexander, et al.. (2010). Development of a drug resistance model in hepatoblastoma. Klinische Pädiatrie. 222(3). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact